Position in MRK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$12,601,995
+$740,078 QoQ
Shares Held
98,070
-0.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#664
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $58,603,256 across 10 Drug Manufacturers - General names. MRK ranks #3 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,432 | $17,220,228 | |
| 2 | JNJ |
Johnson & Johnson
|
50,589 | $12,848,088 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
98,070 | $12,601,995 | |
| 4 | LLY |
ELI LILLY & Co
|
5,314 | $6,373,771 | |
| 5 | AMGN |
Amgen Inc
|
8,505 | $3,079,830 | |
| 6 | PFE |
Pfizer Inc
|
120,987 | $2,913,366 | |
| 7 | NVS |
Novartis AG
|
13,967 | $2,188,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,810 | $607,695 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,601,995 | 98,070 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $11,861,917 | 98,611 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $10,193,167 | 96,838 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $7,841,831 | 93,433 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,411,750 | 93,630 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,575,221 | 95,535 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $9,774,805 | 98,259 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $11,178,165 | 98,434 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,220,545 | 98,712 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,995,178 | 90,907 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,825,318 | 90,124 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,045,084 | 87,859 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,755,416 | 84,543 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $8,550,138 | 80,366 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,731,225 | 60,669 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,474,303 | 63,566 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,758,023 | 63,157 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $4,546,062 | 55,406 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,040,000 | 52,714 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,040,166 | 53,790 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,073,981 | 52,385 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $3,389,263 | 43,965 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,100,873 | 37,908 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,107,972 | 37,468 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,894,308 | 37,428 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,787,227 | 36,226 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||